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It is highly likely that there are 
integrin-dependent and -independ-
ent mechanisms that control trans-
formation induced by oncogenes. 
Inhibition of signaling by β4 integrin 
significantly delayed the mammary 
tumorigenesis induced by ErbB2, 
but did not block it. Although the 
activation of Ras/MAPK mediated by 
ErbB2 could account for the prolif-
eration observed in tumors formed in 
the absence of the β4 integrin signal-
ing domain, it is not known whether 
there are β4-independent mecha-
nisms that mediate ErbB2-induced 
disruption of tight junctions and epi-
thelial organization. Further investi-
gations are needed to answer ques-
tions such as: what are the pathways 
used by oncogenes to disrupt cell 
polarity? Are these pathways selec-
tive for deregulation of cell architec-
ture (Figure 1)?
Such questions lead us to a 
hypothesis. Pathways that deregu-
late cell organization and disrupt cell 
polarity are promising targets for 
cancer therapeutics. Unlike cell pro-
liferation, disruption of cell polarity 
and organization is never observed 
under normal physiological condi-
tions in adult tissue and is unique to 
disease states such as cancer and 
inflammation. If oncogenes disrupt 
epithelial cell polarity using path-
ways that are distinct from those 
involved in the control of prolifera-
tion, further understanding of how 
oncogenes disrupt cell polarity and 
organization can lead to identifica-
tion of new targets for therapeutic 
intervention. Such targets may have 
limited effects on normal cells and 
hence have minimal general toxicity. 
Thus, a comprehensive understand-
ing of the molecular mechanisms 
by which oncogenes disrupt polar-
ity and epithelial organization may 
open doors for a new class of drug 
targets.
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In this issue of Cell, Murgia et al. (2006) confirm that the infectious agent of canine trans-
missible venereal tumor is the cancer cell itself and that the tumor is clonal in origin. Their 
findings have implications for understanding the relationship between genome instability 
and transmissible cancer and for conservation biology, canine genomics, and companion 
animal medicine.Canine transmissible venereal tumor 
(CTVT, also called Sticker’s sarcoma) 
is a contagious venereal tumor found 
in the domestic dog (Canis familiaris) 
and potentially in other social canids, such as the gray wolf (Canis lupus) 
and coyote (Canis latrans). It has 
been proposed that the tumor cells 
themselves—rather than another 
agent such as a virus—constitute Cell 126, Athe contagious agent of this disease. 
In this issue of Cell, Murgia and col-
leagues (2006) address the key issue 
of whether CTVT indeed represents 
a “contagious cancer.”ugust 11, 2006 ©2006 Elsevier Inc. 445
figure 1. Ancestry of the canine Transmissible Venereal Tumor Lineage
The canid phylogeny depicts the origins of canine transmissible venereal tumor (CTVT). The 
LINE-1 element was inserted upstream of c-myc, a proto-oncogene, in the cells of a wolf/dog 
progenitor. CTVT lineage divergence occurred soon after its emergence. The subtypes do not 
necessarily correspond to species. Once the CTVT tumor enters the dog lineage, an infected 
individual can rapidly transmit it (green arrows) by coitus. The tumor can potentially be transmit-
ted among Canis species. Scottish terrier photo courtesy of the American Kennel Club (AKC); 
other dog photos courtesy of Mary Bloom, AKC. Wolf photo courtesy of Priscilla Barrett (D.W. 
MacDonald and P. Barrett, Mammals of Europe [Princeton University Press, Princeton, NJ, USA, 
1993]). Coyote photo courtesy of Dr. Robert K. Wayne.Proponents of the “contagious cell 
line” hypothesis argue that CTVT is 
passed through the population by 
allografts, with the tumor cells from 
one animal directly seeding tumor 
formation in the next, usually dur-
ing coitus (Cohen, 1985; Katzir et al., 
1987). This is supported by the fact 
that CTVT can only be transmitted 
experimentally using living cells, not 
cellular filtrates or killed cells. In addi-
tion, although the tumor is always 
aneuploid, tumors from distinct geo-
graphic regions feature unique chro-
mosomal patterns of gain and loss, 
arguing for local lineages. Finally, all 
tumors are marked by the presence 446 Cell 126, August 11, 2006 ©2006 Elsof a diagnostic long interspersed 
nuclear element (LINE-1) inserted 
near the c-myc gene. The LINE-1 ele-
ment is absent at the corresponding 
position in the germline (Liao et al., 
2003). Skeptics, however, cite mul-
tiple reports of virus-like particles 
found in CTVT tissue. In their new 
study, Murgia et al. (2006) analyze 
microsatellite markers, mitochon-
drial DNA (mtDNA), and major histo-
compatibility (termed dog leukocyte 
antigen [DLA] in dogs) genes in order 
to elucidate the natural history of this 
unusual tumor.
Using both recently collected and 
archival tissue from dogs in loca-evier Inc.tions spanning five continents, the 
authors first established the clonal 
origin of the tumors. All tumors 
contained the tumor-specific LINE-
1 element, even samples collected 
two decades apart. In addition, 
whereas DLA analysis revealed a 
large number of variants in germline 
DNA, only two major haplotypes 
appeared in the tumors, suggest-
ing the existence of just two tumor 
subtypes. Results were supported 
by mtDNA analysis, which grouped 
tumors into two distinct clusters 
within a single clade, clade A, of the 
canine phylogeny. Germline mtDNA 
from the same dogs was distrib-
uted among three clades (Murgia et 
al., 2006).
The authors then investigated the 
origin of the tumors. Both DLA poly-
morphism and microsatellite data 
indicated that all tumor samples 
were closely related to DNA from 
wolves and East Asian dog breeds, 
providing convincing evidence for 
a common origin (Figure 1). Micro-
satellite analysis of the two CTVT 
subgroups revealed an equiva-
lent degree of variation, implying 
a divergence event soon after the 
emergence of the original tumor. 
Assuming about the same mutation 
rate in canine microsatellite DNA as 
in human microsatellite DNA (10−3 
to 10−4), divergence between the 
two CTVT subgroups is estimated 
to have taken place 200 to 2500 
years ago.
How does CTVT evade the host’s 
immune system? One possibility is 
that the tumor suppresses the DLA 
antigen activity of the host. Indeed, 
Murgia et al. (2006) observed 
that CTVT tumors downregulated 
expression of class I molecules and 
that class II activity was completely 
absent, generating a mechanism 
for avoiding detection. In CTVT, 
tumor cells decrease DLA activity 
by secreting the inhibitory factors 
TGF-β1 and interleukin 6. This is 
a unique evolutionary adaptation 
that rarely results in death for the 
infected animal, thus guaranteeing 
tumor transmission during the next 
breeding cycle. Further character-
ization of CTVT adaptations may 
provide clues to the more famil-
iar problem of understanding how 
viruses escape host surveillance.
The success of this single cell 
lineage, believed to be the longest 
continually propagated cell lineage 
in the world, can be attributed to 
the tumor’s mode of transmission 
in a specific host system. Although 
direct contact is generally not a 
highly efficient mode of transfer, 
CTVT takes advantage of the “pop-
ular sire” effect of domestic dogs. A 
single male can produce dozens of 
litters over his lifetime, allowing the 
tumor to affect many more females 
than it could if a monogamous spe-
cies were the host. Understanding 
the epidemiology of CTVT will pro-
vide insights for populations that 
may experience CTVT exposure and 
information about disease preva-
lence. CTVT is more often found 
in temperate climates where there 
are large populations of stray dogs, 
but little is known about the details 
of transmission. Is male-to-female 
transmission more effective, or vice 
versa? Can tumors be transmitted 
via artificial insemination (Moulton, 
1978; Cohen, 1985)? The latter is a 
particular concern as many canids, 
both domestic and wild, are impreg-
nated via artificial methods. Learn-
ing more about the details of tumor 
transmission is key for understand-
ing how more aggressive forms of 
the tumor, should they evolve, will 
spread through the population.
As a result of this work, both 
oncologists and evolutionary biolo-
gists must now question why allo-
grafting is not a more common 
mode of transmission both for 
tumors and for viruses. Consistent 
with this possibility, genomic inser-
tions of LINE-1 have the potential 
to disrupt transcriptional regula-
tion of downstream genes, pos-
sibly initiating oncogenic activity, 
as is the case with CTVT, where 
LINE-1 inserts close to the c-myc 
gene. Thirty-four percent of the 
dog genome consists of repetitive 
elements. Indeed, Bentolila et al. (1999) have described a particular 
3′ open reading frame (ORF) that 
shares sequence homology with 
a viral reverse transcriptase, pro-
viding a plausible mechanism for 
genome jumping. However, despite 
its many specialized adaptations, 
CTVT rarely becomes disseminated 
in an immunocompetent animal, 
highlighting the importance of the 
host immune response in suscepti-
bility to a transmissible cell lineage. 
Moreover, other nonviral transmis-
sible tumors have been described, 
but they tend to be aggressive, such 
as the Tasmanian devil facial tumor 
and the Syrian hamster tumor, 
both of which result in rapid tumor 
growth and host death (Pearse and 
Swift, 2006).
In addition to their implications 
for tumor biology and companion 
animal medicine, these findings 
have implications for conservation 
biology and genome evolution. At 
present, CTVT can enter the wild 
canid population through physical 
contact between individuals (lick-
ing and biting) or mating between 
closely related species such as 
gray wolves, coyotes, and domes-
tic dogs. For highly endangered 
canids, exposure to CTVT could 
theoretically create an immediate 
threat to the population’s survival. 
Virtually nothing is known about the 
immune response to CTVT in wild 
canids.
Despite the above concerns, 
CTVT can prove useful for stud-
ies of population dynamics, serv-
ing as a molecular proxy for the 
host. Proxy (parasite, virus, tumor) 
genomes generally evolve at a 
faster rate than host DNA, provid-
ing an accurate measure of host 
gene flow and migration when 
other genetic markers are uninfor-
mative (Whiteman and Parker 2005; 
Biek et al., 2006). For example, 
analysis of feline immunodeficiency 
virus (FIV) genes indicated strong 
genetic separation between popu-
lations of North American moun-
tain lions (Puma concolor) within Cell 126, Aa defined geographic region when 
host microsatellite DNA and mtDNA 
data were uninformative (Biek et al., 
2006). Similar applications would 
be beneficial for elucidating host 
species demography, especially 
when hosts are highly mobile and 
social, as are most Canis species.
The prospect of a contagious 
cancer cell is at once intriguing and 
frightening. Important directions 
for future study include expression 
profiling of DLA antigens during 
tumorigenesis and regression. Also 
important will be investigations into 
the origins of the LINE-1 transposi-
tion and evolutionary pressures that 
conserve the aneuploid genomic 
structure of CTVT. At any rate, if 
and when a more toxic contagious 
cancer emerges, we should not be 
surprised. Ever vigilant, man’s best 
friend has warned him of dangers 
to come.
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